Conferences  >  Medicine & Healthcare  >  Pharmacology and Drug Development

Virtue Insight

38th Pharmacovigilance USA 2025 will bring together top pharmaceutical, biotechnology and regulatory, vendor representatives under one roof that will address the key issues of the industry. Get more from the event, with a broader scope bringing the whole communications value chain together.

Phone: [+44 2035093779];     Email: Kavitha@virtueinsight.co.in

Pharmacovigilance, regulatory affairs, Drug Safety, Drug Development, patient safety, RiskManagement, Pharmaceuticals, healthcare

World High Technology Society

The Annual Congress of International Drug Discovery Science and Technology (IDDST) initiated since 2003, it has been successfully hosted in Shanghai (China), Beijing (China), Shenzhen(China), Nanjing (China), Haikou(China), Suzhou (China), Xi'an(China), Gyeonggi (South Korea), Osaka (Japan), Boston (USA), Kyoto (Japan), Tokyo (Japan) and Amsterdam (the Netherlands) and has attracted more than 10,000 participants from over 50 countries and regions in the previous 20 years.

Organizing Committee of IDDST;     Phone: [0086-411-84799629];     Email: irene@iddst.com

World High Technology Society

The Annual Congress of International Drug Discovery Science and Technology (IDDST) initiated since 2003, it has been successfully hosted in Shanghai (China), Beijing (China), Shenzhen(China), Nanjing (China), Haikou(China), Suzhou (China), Xi'an(China), Gyeonggi (South Korea), Osaka (Japan), Boston (USA), Kyoto (Japan), Tokyo (Japan) and Amsterdam (the Netherlands) and has attracted more than 10,000 participants from over 50 countries and regions in the previous 20 years.

Organizing Committee of IDDST;     Phone: [0086-411-84799629];     Email: irene@iddst.com

Veridon Global Pvt Ltd

The EuroPotent Therapeutics Summit, hosted by Veridon Global is set to convene leading experts, innovators, and decision-makers in the field of high-potency active pharmaceutical ingredients (HPAPI) and potent therapeutic development. It will take place on 22nd-23rd May 2025 in Frankfurt, Germany, offering an unparalleled platform for professionals in the pharmaceutical and biotech sectors to explore the latest developments in HPAPI. With Europe at the forefront of global regulatory standards, this summit will provide a comprehensive overview of the evolving regulatory landscape, with a focus on compliance challenges, emerging technologies, and cutting-edge safety practices specific to HPAPI manufacturing. Key themes will include advancements in containment and isolation technologies, environmental sustainability, and the integration of digital tools to optimize production processes while ensuring safety and regulatory adherence.

Phone: [+1 6672600490];     Email: marketing@veridonglobal.com

EuroPotent Therapeutics Summit, EuroPotent Therapeutics Conference, EuroPotent Therapeutics, Pharma conference in Europe, high-potency active pharmaceutical ingredients, HPAPI, HPAPI development, HPAPI manufacturing, drug development

Veridon Global Pvt Ltd

Veridon Global is proud to present the EVIDENCE 360: RWE, Pricing & Reimbursement Summit Europe on 26th-27th May 2025 in Frankfurt, Germany. This two-day summit is a must-attend event for healthcare professionals, pharmaceutical leaders, policymakers, and researchers, offering an in-depth exploration of the latest trends, challenges, and innovations in Real-World Evidence (RWE), pricing strategies, and reimbursement frameworks in Europe.

As the healthcare landscape evolves, RWE is becoming increasingly vital for decision-making, influencing how drugs are priced, reimbursed, and integrated into healthcare systems. This summit will address the current challenges in RWE adoption, including the complexities of data quality, integration of electronic health records, addressing key topics such as the integration of RWE into pricing strategies, the alignment of RWE with health technology assessments (HTAs), and the complexities surrounding cross-border reimbursement policies. Attendees will gain valuable insights into the evolving role of RWE in shaping pricing models and market access strategies within the European context, focusing on how healthcare systems are evolving to incorporate this data for more value-based and patient-centric decisions.

Phone: [+1 6672600490];     Email: marketing@veridonglobal.com

EVIDENCE 360, EVIDENCE 360 summit, Real-World Evidence, Real-World Evidence trends, Real-World Evidence summit, Real-World Evidence conference in Europe,

Uventia Global

The Visual Inspection in Parenterals summit is a premier event that brings together experts from the pharmaceutical and biotechnology sectors to explore best practices, technologies and advancements in the visual inspection of parenteral products. Parenterals, which include injectable drugs and biologics, require stringent quality control measures to ensure their safety and efficacy. This conference will cover a wide range of topics such as the latest innovations in automated and manual visual inspection techniques, detection of particulate matter, container-closure integrity and regulatory requirements. Attendees will gain insights into cutting-edge technologies, industry standards and case studies aimed at enhancing the accuracy and reliability of visual inspections. The event will also provide valuable networking opportunities for professionals to collaborate and share expertise, fostering improvements in product quality and patient safety. This conference is essential for anyone involved in the manufacturing, testing and regulation of parenteral products.

Email: info@uventia.com

Regulatory and Compendial Requirements for Visual Inspection, Lifecycle Approach in Visual Inspection and Particle Management, Risk-Based Validation Case Studies, Inspector Training and Qualification, Deep Learning (DL) and Artificial Intelligence (AI) for Visual Inspection, Defect Classifications: Categorizing Defects and Nonconformities, Particulate Matter: Classification, Characterization & Control, Container Integrity Inspection and Leak Detection, New solutions for quality control of difficult to inspect parenterals

Regulation in Medicine and Pharmacology,    Biotechnology

European Society for Medical Oncology

ESMO TAT, the multi-stakeholder forum gathering key actors in cancer drug development, arrives in one of the most dynamic and best-connected hubs in Asia, making the latest advances in early clinical trials accessible to everyone in the region. Through in-depth discussions on critical topics such as innovation, digital transformation, research methodology, business insights, regulation, and public policy, ESMO TAT Asia aims to drive progress in cancer treatment and research. Located in the lively city of Hong Kong, ESMO TAT Asia promises to be a vibrant gathering with region’s industry, academia, clinicians, and regulators to promote international cooperation and accelerate the anticancer research. Come and join us to chart new paths in cancer drug development in Asia.

ESMO Asia TAT 2025 Secretariat;     Email: asiacongress@esmo.org

targeted therapies, early drug development, cancer therapeutics, immunotherapy, cytotoxic therapy, cell therapy, biotech, pharmaceutical industry

CHI

Join a global community of thought leaders and innovators shaping the future of bioprocessing. Dive into cutting-edge research, share insights with industry experts, and tackle the challenges of bioprocess R&D, scale-up, quality, and analytics.

Phone: [781.972.5400];     Email: chi@healthtech.com

World High Technology Society

The Annual Congress of International Drug Discovery Science & Technology (IDDST), initiated from 2003, has been successfully organized in Shanghai (China), Beijing (China), Shenzhen (China), Nanjing (China), Haikou (China), Suzhou (China), Xi’an (China), Gyeonggi (South Korea), Osaka (Japan), Boston (USA), Kyoto (Japan), Tokyo (Japan), Amsterdam (the Netherlands), Osaka (Japan) and Budapest (Hungary) and has attracted more than 10000 participants from over 50 countries and regions in the previous 20 years. The 21th IDDST (Europe) will be held during June 18-20, 2025 at Stockholm, Sweden. It continues to expand with magnificent scientific and social programs to maximize your network in a free communication meeting environment.

The 21th IDDST (Europe) will host leading scientists from the academia and industry worldwide, to discuss the latest developments in drug discovery and therapy. The program of the coming conference promises to be very interesting for both basic scientists and executives who are working in the field of drug discovery and other related areas, they will offer complete updates of recent developments and present the latest results in the remarkable separate tracks. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better practice and application.

Magnus Group

Prepare to immerse yourself in the 5th Edition of the International Vaccines Congress (IVC 2025), taking place from October 23-25, 2025, in the vibrant city of Orlando, Florida, USA! This highly anticipated International Vaccines Congress 2025 will offer a unique hybrid format, seamlessly blending onsite and online experiences to maximize global reach and participation. Dive deep into the latest advancements and transformative trends in vaccine science under the theme: From Discovery to Distribution: The Path of Vaccines.

Phone: [17029882320];     Email: vaccines@magnusconference.com